~~<i id='7327A540C2'><strike id='7327A540C2'><tt id='7327A540C2'><pre id='7327A540C2'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

focus

author：hotspot 2025-10-03 00:39:53 - browse：34681

Two business miniatures talk to each other on coin stacks that are sandwiched by a syringe and a stethoscope — coverage from STAT — Adobe

For all the flak they get, the country’s four biggest pharmacy benefit managers reported a surprisingly tame average profit margin in the first three quarters of 2023: 4.5%, less than a third of their drugmaker peers.

But don’t take their numbers as gospel, experts warned.

“It’s really easy to move money around inside the books of a vertically integrated organization,” said Karen Van Nuys, a senior fellow at the USC Schaeffer Center for Health Policy and Economics. “If one segment of your vertically integrated organization is not publishing any financial data, it’s a good place to hide stuff.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： H5N1 bird flu: what we're starting to learn about infection in cows

hotspot

entertainment

Wikipedia

hotspot

entertainment

explore

AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

WSS

At least 13 dead in Texas as scorching temps continue

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

H5N1 bird flu: what we're starting to learn about infection in cows

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Continuity nursing helped my family in our darkest PICU moments

leisure time

focus

hotspot

Peter Hotez and the public health issue of online harassment

Software glitch causes Tandem insulin pump to shutdown, FDA warns

What does generative AI mean for health care? We asked experts

Shionogi licenses Pompe disease therapy from Maze Therapeutics

Medical records are filled with copy

Use wet bulb globe temperature, not heat index, to protect workers

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Sanofi strikes deal with Novavax, boosting the vaccine maker

Hepatitis C has a cure — but many Americans still lack access to it

Psychedelics group wrestles with new pharma identity

entertainment

Software glitch causes Tandem insulin pump to shutdown, FDA warns

Making AI in medicine accessible to smaller, and rural hospitals

First recipient of genetically engineered pig kidney has died

Shionogi licenses Pompe disease therapy from Maze Therapeutics

Brain worms: The science behind RFK Jr.'s parasitic infection

Activists slam private health insurers over coverage restrictions

Wikipedia

hotspot

entertainment

explore